v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional Paid in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Treasury Stock Amount
Balance at the beginning (in shares) at Dec. 31, 2020   396,303 393,014        
Balance at the beginning at Dec. 31, 2020 $ 2,631,345 $ 40 $ 39 $ 5,067,135 $ (2,230,619) $ 83,534 $ (288,784)
Increase (Decrease) in Stockholders' Equity              
Exercise of stock options (in shares)   2,857          
Exercise of stock options 7,638     7,638      
Stock-based compensation 151,843     151,843      
Purchase of capped call options (123,970)     (123,970)      
Equity consideration issued for acquisition (in shares)   464          
Equity consideration issued for acquisition 29,399     29,399      
Shares issued for exercise of warrants (in shares)   138          
Shares issued for exercise of warrants 1,761     1,761      
Purchase of treasury stock (in shares)   (48)          
Purchase of treasury stock (3,124)           (3,124)
Restricted stock unit vesting (in shares)   178          
Foreign currency translation, net of nil tax (27,318)         (27,318)  
Net loss (346,344)       (346,344)    
Balance at the end (in shares) at Mar. 31, 2021   399,892 393,014        
Balance at the end at Mar. 31, 2021 2,321,230 $ 40 $ 39 5,133,806 (2,576,963) 56,216 (291,908)
Balance at the beginning (in shares) at Dec. 31, 2020   396,303 393,014        
Balance at the beginning at Dec. 31, 2020 2,631,345 $ 40 $ 39 5,067,135 (2,230,619) 83,534 (288,784)
Increase (Decrease) in Stockholders' Equity              
Equity consideration issued for acquisition 33,149            
Foreign currency translation, net of nil tax (32,719)            
Net loss (1,196,898)            
Balance at the end (in shares) at Sep. 30, 2021   405,345 393,014        
Balance at the end at Sep. 30, 2021 1,826,167 $ 40 $ 39 5,505,908 (3,427,517) 50,815 (303,118)
Balance at the beginning (in shares) at Mar. 31, 2021   399,892 393,014        
Balance at the beginning at Mar. 31, 2021 2,321,230 $ 40 $ 39 5,133,806 (2,576,963) 56,216 (291,908)
Increase (Decrease) in Stockholders' Equity              
Exercise of stock options (in shares)   1,878          
Exercise of stock options 10,816     10,816      
Stock-based compensation 171,739     171,739      
Equity consideration issued for acquisition (in shares)   56          
Equity consideration issued for acquisition 3,750     3,750      
Shares issued for exercise of warrants (in shares)   43          
Shares issued for exercise of warrants 2,419     2,419      
Purchase of treasury stock (in shares)   (115)          
Purchase of treasury stock (6,773)           (6,773)
Restricted stock unit vesting (in shares)   739          
Foreign currency translation, net of nil tax 7,697         7,697  
Net loss (305,526)       (305,526)    
Balance at the end (in shares) at Jun. 30, 2021   402,493 393,014        
Balance at the end at Jun. 30, 2021 2,205,352 $ 40 $ 39 5,322,530 (2,882,489) 63,913 (298,681)
Increase (Decrease) in Stockholders' Equity              
Exercise of stock options (in shares)   2,607          
Exercise of stock options 6,664     6,664      
Stock-based compensation 175,664     175,664      
Shares issued for exercise of warrants (in shares)   28          
Shares issued for exercise of warrants 1,050     1,050      
Purchase of treasury stock (in shares)   (80)          
Purchase of treasury stock (4,437)           (4,437)
Restricted stock unit vesting (in shares)   297          
Foreign currency translation, net of nil tax (13,098)         (13,098)  
Net loss (545,028)       (545,028)    
Balance at the end (in shares) at Sep. 30, 2021   405,345 393,014        
Balance at the end at Sep. 30, 2021 1,826,167 $ 40 $ 39 5,505,908 (3,427,517) 50,815 (303,118)
Balance at the beginning (in shares) at Dec. 31, 2021   407,781 393,014        
Balance at the beginning at Dec. 31, 2021 1,678,528 $ 41 $ 39 5,702,388 (3,753,814) 36,488 (306,614)
Increase (Decrease) in Stockholders' Equity              
Exercise of stock options (in shares)   913          
Exercise of stock options 1,770     1,770      
Stock-based compensation 187,077     187,077      
Purchase of treasury stock (in shares)   (793)          
Purchase of treasury stock (14,083)           (14,083)
Restricted stock unit vesting (in shares)   9,327          
Restricted stock unit vesting 1 $ 1          
Net loss (467,693)       (467,693)    
Balance at the end (in shares) at Mar. 31, 2022   417,228 393,014        
Balance at the end at Mar. 31, 2022 1,385,600 $ 42 $ 39 5,891,235 (4,221,507) 36,488 (320,697)
Balance at the beginning (in shares) at Dec. 31, 2021   407,781 393,014        
Balance at the beginning at Dec. 31, 2021 $ 1,678,528 $ 41 $ 39 5,702,388 (3,753,814) 36,488 (306,614)
Increase (Decrease) in Stockholders' Equity              
Exercise of stock options (in shares) 12,945            
Equity consideration issued for acquisition $ 460,128            
Foreign currency translation, net of nil tax 0            
Net loss (1,135,290)            
Balance at the end (in shares) at Sep. 30, 2022   448,664 393,014        
Balance at the end at Sep. 30, 2022 1,435,116 $ 45 $ 39 6,616,274 (4,889,104) 36,488 (328,626)
Balance at the beginning (in shares) at Mar. 31, 2022   417,228 393,014        
Balance at the beginning at Mar. 31, 2022 1,385,600 $ 42 $ 39 5,891,235 (4,221,507) 36,488 (320,697)
Increase (Decrease) in Stockholders' Equity              
Exercise of stock options (in shares)   902          
Exercise of stock options 3,131     3,131      
Stock-based compensation 135,521     135,521      
Equity consideration issued for acquisition (in shares)   29,252          
Equity consideration issued for acquisition 460,128 $ 3   460,125      
Purchase of treasury stock (in shares)   (254)          
Purchase of treasury stock (3,393)           (3,393)
Restricted stock unit vesting (in shares)   894          
Net loss (217,103)       (217,103)    
Balance at the end (in shares) at Jun. 30, 2022   448,022 393,014        
Balance at the end at Jun. 30, 2022 1,763,884 $ 45 $ 39 6,490,012 (4,438,610) 36,488 (324,090)
Increase (Decrease) in Stockholders' Equity              
Exercise of stock options (in shares)   69          
Exercise of stock options 224     224      
Stock-based compensation 126,038     126,038      
Purchase of treasury stock (in shares)   (267)          
Purchase of treasury stock (4,536)           (4,536)
Restricted stock unit vesting (in shares)   840          
Foreign currency translation, net of nil tax 0            
Net loss (450,494)       (450,494)    
Balance at the end (in shares) at Sep. 30, 2022   448,664 393,014        
Balance at the end at Sep. 30, 2022 $ 1,435,116 $ 45 $ 39 $ 6,616,274 $ (4,889,104) $ 36,488 $ (328,626)